e8a2 BCR-ABL: More frequent than other atypical BCR-ABL variants? [5]

Leukemia

Volumn 19, Issue 4, 2005, Pages 681-684

  Demehri, S ^a   Paschka, P ^b   Schultheis, B ^b   Lange, T ^c   Koizumi, T ^d   Sugimoto, T ^d   Branford, S ^e   Lim, L C ^f   Kegel, T ^g   Martinelli, G ^h   Hochhaus, A ^b   Druker, B J ^a,i   Deininger, M W N ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d HYOGO MEDICAL CENTER FOR ADULTS   (Japan)

^e INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^f SINGAPORE GENERAL HOSPITAL   (Singapore)

^g MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^h UNIVERSITY OF BOLOGNA   (Italy)

ⁱ HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BCR ABL PROTEIN; BUSULFAN; CYTARABINE; HYDROXYUREA; IMATINIB;

ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; BLOOD ANALYSIS; CHROMOSOME 22; CHROMOSOME 9; CHROMOSOME ANALYSIS; CHROMOSOME BREAKAGE; CHROMOSOME TRANSLOCATION 22; CHROMOSOME TRANSLOCATION 9; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE REARRANGEMENT; GENETIC VARIABILITY; HUMAN; KARYOTYPING; LETTER; LEUKEMIA REMISSION; MALE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS;

EID: 20244372273     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2403604     Document Type: Letter

References (8)

1. Melo JV. The diversity of BCR-ABL fusion proteins and their relationship to leukemia phenotype. Blood 1996; 88: 2375-2384.
2. Martinelli G, Amabile M, Giannini B, Terragna C, Ottaviani E, Soverini S et al. Novel types of bcr-abl transcript with breakpoints in BCR exon 8 found in Philadelphia positive patients with typical chronic myeloid leukemia retain the sequence encoding for the DBL- and CDC24 homology domains but not the pleckstrin homology one. Haematologica 2002; 87: 688-694.
3. Schultheis B, Wang L, Clark RE, Melo JV. BCR-ABL with an e6a2 fusion in a CML patient diagnosed in blast crisis. Leukemia 2003; 17: 2054-2055.
4. Lemmon MA, Ferguson KM. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J 2000; 350 (Part 1): 1-18.
5. Han J, Luby-Phelps K, Das B, Shu X, Xia Y, Mosteller RD et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 1998; 279: 558-560.
6. Chuang TH, Xu X, Kaartinen V, Heisterkamp N, Groffen J, Bokoch GM. Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family. Proc Natl Acad Sci USA 1995; 92: 10282-10286.
7. Lugo TG, Pendergast AM, Muller AJ, Witte ON. Tyrosine kinase activity and transformation potency of bcr-abl oncogene products. Science 1990; 247: 1079-1082.
8. Kin Y, Li G, Shibuya M, Maru Y. The Dbl homology domain of BCR is not a simple spacer in P210 BCR-ABL of the Philadelphia chromosome. J Biol Chem 2001; 276: 39462-39468.